These findings highlight that, unlike a straightforward “gatekeeper” tumor suppressor, LKB1’s role in PCa is dynamically shaped by the tumor milieu—including epigenetic modifications, protein stability, and crosstalk with other oncogenic alterations. Here, STK11 is linked to posterior cortical atrophy.